Transplanting beneficial bacteria colonies into Parkinson’s disease mice (Sun et al., 2018) could protect these mice through inhibiting neuroinflammation and reducing TLR4/TNF-α signaling. This evidence concerns the gene TLR4 and Parkinson disease.